Table 2– Exercise testing data
Control group#COPD group
Baselinep-value+BaselineFollow-upp-value§
Treadmill testing
VO2,peak mL·kg−1·min−138.9±5.00.00520.4±4.020.2±3.6**0.68
 WE mL·kg−1·min−1ND11.0±0.610.6±0.50.44
VE at peak work L·min−187±80.00149±949±11***0.87
Knee-extensor testing
 Peak work W23.2±6.70.0314.6±4.920.0±5.30.001
 Quadriceps muscle mass kg1.64±0.200.101.39±0.271.43±0.260.45
 Femoral blood flow at 6 Watts L·min−11185±2360.851213±2421195±2500.87
 Femoral blood flow at peak work L·min−12854±1680.032127±6552631±3480.03
 Muscle VO2 at 6 Watts mL·kg−1·min−1ND117±30104±290.26
 Muscle VO2 at peak work mL·kg−1·min−1ND200±40248±430.048
 Pulmonary VO2 at 6 Watts mL·kg−1·min−15.21±1.210.077.81±2.675.78±1.290.026
 Pulmonary VO2 at peak work mL·kg−1·min−114.6±4.90.03610.9±1.811.7±1.20.30
 Lactate at 6 Watts mmol·L−1ND2.16±1.021.67±1.130.17
 Lactate at peak work mmol·L−1ND4.4±2.26.3±2.30.06
VE at 6 Watts L·min−113.0±1.20.0216.7±2.713.3±2.00.007
VE at peak work L·min−133.9±9.90.1627.4±4.329.3±2.80.18
  • Data are presented as mean±sd, unless otherwise stated. COPD: chronic obstructive pulmonary disease; VO2,peak: peak oxygen consumption; WE: work economy; VE: minute ventilation; VO2: oxygen uptake; ND: no data. #: n=5; : n=7; +: significance levels between baseline control and baseline COPD; §: significance levels between baseline COPD and follow-up COPD. **: p<0.01; ***: p<0.001 between controls and COPD at follow-up.